RecruitingNot ApplicableNCT06804837

Implement and Test Visual Consent Template and Process


Sponsor

Washington University School of Medicine

Enrollment

515 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators plan to conduct a stepped wedge randomized control trial to implement and test the consent template and process in three studies. Randomization will occur at the research coordinator/research team level. Each participating research team member will begin in the standard consent arm of the study. Subsequently, they will be randomized to the visual key information page arm at staggered time points to undergo training and begin using the visual key information page with patients who are eligible for the selected research study.


Eligibility

Min Age: 18 Years

Inclusion Criteria21

  • Eligibility Criteria for Patients:
  • Adult participants (18+) eligible for one of three participating trials at Washington University, University of Utah, or University of North Carolina at Chapel Hill. The eligibility criteria for the main trials are below:
  • UNC:
  • Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information.
  • Participant is willing and able to comply with study procedures based on the judgment of the investigator.
  • Age ≥ 18 years at the time of consent.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1.
  • Consent to a mandatory pre-study biopsy if archival tissue is not available or sufficient.
  • Participants with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen.
  • Washington University:
  • Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies (WeSHARE)
  • Participants of the Knight Alzheimer Disease Research Center.
  • Participants with available results from an Alzheimer Disease blood biomarker test.
  • Participants who agreed to be contacted for additional research studies.
  • University of Utah:
  • Huntsman Cancer Institute Total Cancer Care
  • Participants who have been diagnosed with any type of tumor or cancer.
  • Participants with genetic predispositions or family history of cancer or tumors.
  • Participant volunteers willing to share samples and data for research.
  • Eligibility Criteria for Research Staff:
  • Research staff/coordinators of one of the three participating trials at Washington University, University of Utah, or University of North Carolina at Chapel Hill.

Interventions

OTHERVisual consent

Visual key information page

OTHERStandard consent

Summary text only


Locations(3)

Washington University School of Medicine

St Louis, Missouri, United States

University of North Carolina at Chapel Hill School of Medicine

Chapel Hill, North Carolina, United States

University of Utah Huntsman Cancer Institute (HCI)

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06804837


Related Trials